The role of hypercoagulability in venous and arterial thrombosis.
D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000302:isolation & purification; D001777:Blood Coagulation / Q000187:drug effects; D001778:Blood Coagulation Disorders / Q000503:physiopathology*; D001779:Blood Coagulation Factors / Q000502:physiology; D001783:Blood Flow Velocity; D001789:Blood Group Antigens; D003094:Collagen / Q000378:metabolism; D003276:Contraceptives, Oral / Q000009:adverse effects; D004211:Disseminated Intravascular Coagulation / Q000503:physiopathology; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism; D010973:Platelet Adhesiveness; D013917:Thrombin / Q000378:metabolism; D013923:Thromboembolism / Q000503:physiopathology; D013924:Thrombophlebitis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D013927:Thrombosis / Q000188:drug therapy / Q000503:physiopathology*
D000925:Anticoagulants; D000991:Antithrombins; D001779:Blood Coagulation Factors; D001789:Blood Group Antigens; D003276:Contraceptives, Oral; D004967:Estrogens; D005340:Fibrinogen; D003094:Collagen; D013917:Thrombin